S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
NASDAQ:CYTK

Cytokinetics News Headlines

$36.89
-1.24 (-3.25 %)
(As of 10/15/2021 04:00 PM ET)
Add
Compare
Today's Range
$36.77
$38.97
50-Day Range
$29.52
$38.85
52-Week Range
$14.89
$39.46
Volume768,628 shs
Average Volume1.18 million shs
Market Capitalization$3.08 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.41

Media Mentions By Week

Cytokinetics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYTK
News Sentiment

0.39

0.34

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYTK Articles
This Week

17

5

CYTK Articles
Average Week

Get Cytokinetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter.

Cytokinetics (NASDAQ CYTK) News Headlines Today

SourceHeadline
MarketBeat logoFady Ibraham Malik Sells 2,000 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) Stock
americanbankingnews.com - October 14 at 8:22 PM
nasdaq.com logoHow Much Upside is Left in Cytokinetics (CYTK)? Wall Street Analysts Think 37% - Nasdaq
nasdaq.com - October 11 at 3:03 PM
finance.yahoo.com logoHow Much Upside is Left in Cytokinetics (CYTK)? Wall Street Analysts Think 37%
finance.yahoo.com - October 11 at 3:03 PM
benzinga.com logoWhere Cytokinetics Stands With Analysts - Benzinga - Benzinga
benzinga.com - October 8 at 4:22 PM
MarketBeat logoCytokinetics (NASDAQ:CYTK) Stock Rating Reaffirmed by HC Wainwright
americanbankingnews.com - October 8 at 12:30 PM
finance.yahoo.com logoCytokinetics Outlines Go-To-Market Strategy for Omecamtiv Mecarbil and Provides Updates on Cardiovascular Pipeline at Today’s Analyst & Investor Day - Yahoo Finance
finance.yahoo.com - October 8 at 6:21 AM
MarketBeat logoCytokinetics (NASDAQ:CYTK) Stock Price Up 8.1%
americanbankingnews.com - October 7 at 12:44 PM
benzinga.com logoExpert Ratings For Cytokinetics - Benzinga - Benzinga
benzinga.com - October 7 at 12:38 PM
streetinsider.com logoCytokinetics (CYTK) Outlines Go-To-Market Strategy for Omecamtiv Mecarbil and Provides Updates on Cardiovascular Pipeline - StreetInsider.com
streetinsider.com - October 7 at 7:38 AM
globenewswire.com logoCytokinetics Outlines Go-To-Market Strategy for Omecamtiv Mecarbil and Provides Updates on Cardiovascular Pipeline at - GlobeNewswire
globenewswire.com - October 7 at 7:38 AM
finance.yahoo.com logoCytokinetics Outlines Go-To-Market Strategy for Omecamtiv Mecarbil and Provides Updates on Cardiovascular Pipeline at Today’s Analyst & Investor Day
finance.yahoo.com - October 7 at 7:38 AM
MarketBeat logoJefferies Financial Group Begins Coverage on Cytokinetics (NASDAQ:CYTK)
americanbankingnews.com - October 6 at 8:37 PM
MarketBeat logoCytokinetics (NASDAQ:CYTK) Reaches New 52-Week High at $36.90
americanbankingnews.com - October 4 at 2:42 PM
seekingalpha.com logoCircling Back On Cytokinetics - Seeking Alpha
seekingalpha.com - October 3 at 9:09 PM
MarketBeat logoCytokinetics, Incorporated (NASDAQ:CYTK) Insider David Cragg Sells 7,569 Shares
americanbankingnews.com - October 1 at 5:26 PM
MarketBeat logoCytokinetics (NASDAQ:CYTK) Trading Up 6%
americanbankingnews.com - September 30 at 12:58 PM
cnbc.com logoCramer's lightning round: Cytokinetics is a very good speculative play - CNBC
cnbc.com - September 28 at 7:54 PM
finance.yahoo.com logoCytokinetics Announces Fourth Annual Communications Fellowship Grant Program Call for Proposals - Yahoo Finance
finance.yahoo.com - September 28 at 2:52 PM
benzinga.com logoThe Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive - Benzinga
benzinga.com - September 28 at 9:51 AM
globenewswire.com logoCytokinetics Announces Fourth Annual Communications Fellowship Grant Program Call for Proposals - GlobeNewswire
globenewswire.com - September 28 at 9:51 AM
finance.yahoo.com logoCytokinetics Announces Fourth Annual Communications Fellowship Grant Program Call for Proposals
finance.yahoo.com - September 28 at 9:51 AM
MarketBeat logoCytokinetics (NASDAQ:CYTK) Sets New 12-Month High at $35.47
americanbankingnews.com - September 27 at 12:58 PM
finance.yahoo.com logoCytokinetics to Host Analyst & Investor Day on October 7, 2021 - Yahoo Finance
finance.yahoo.com - September 25 at 6:47 PM
globenewswire.com logoCytokinetics to Host Analyst & Investor Day on October 7, 2021 - GlobeNewswire
globenewswire.com - September 23 at 6:30 PM
finance.yahoo.com logoCytokinetics to Host Analyst & Investor Day on October 7, 2021
finance.yahoo.com - September 23 at 6:30 PM
streetinsider.com logoCytokinetics (CYTK) Announces Results From REDWOOD-HCM and GALACTIC-HF Trials at the HFSA Annual Scientific Meeting - StreetInsider.com
streetinsider.com - September 13 at 6:47 AM
finance.yahoo.com logoCytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting
finance.yahoo.com - September 12 at 3:45 PM
nasdaq.com logoNoteworthy Friday Option Activity: IIPR, TWTR, CYTK
nasdaq.com - September 12 at 9:48 AM
finance.yahoo.com logoCytokinetics to Participate in September Investor Conferences - Yahoo Finance
finance.yahoo.com - September 8 at 4:24 PM
finance.yahoo.com logoCytokinetics to Participate in September Investor Conferences
finance.yahoo.com - September 8 at 4:24 PM
globenewswire.com logoCytokinetics to Host Investor Call and Webcast to Discuss the Full Results From Redwood-HCM at the HFSA Annual Scientific Meeting - GlobeNewswire
globenewswire.com - September 7 at 12:51 PM
finance.yahoo.com logoCytokinetics to Host Investor Call and Webcast to Discuss the Full Results From Redwood-HCM at the HFSA Annual Scientific Meeting
finance.yahoo.com - September 7 at 12:51 PM
finance.yahoo.com logoCytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF to Be Presented in Late Breaking Clinical Trials Session at the HFSA Annual Scientific Meeting - Yahoo Finance
finance.yahoo.com - September 2 at 10:39 PM
globenewswire.com logoCytokinetics Announces Results From REDWOOD-HCM and - GlobeNewswire
globenewswire.com - August 31 at 11:00 AM
nasdaq.com logoNoteworthy ETF Outflows: XBI, TBIO, EDIT, CYTK - Nasdaq
nasdaq.com - August 22 at 5:17 PM
globenewswire.com logoCytokinetics and Cure SMA Renew Partnership to Advance - GlobeNewswire
globenewswire.com - August 19 at 1:08 PM
bloomberg.com logoCytokinetics CEO Robert Blum on Biopharma Outlook - Bloomberg
bloomberg.com - August 12 at 7:50 PM
benzinga.com logoUnderstanding Cytokinetics's Unusual Options Activity
benzinga.com - August 9 at 7:18 PM
fool.com logoCytokinetics, Incorporated (CYTK) Q2 2021 Earnings Call Transcript - Motley Fool
fool.com - August 6 at 12:39 PM
finance.yahoo.com logoCytokinetics, Incorporated (CYTK) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 6 at 12:39 PM
globenewswire.com logoCytokinetics Reports Second Quarter 2021 Financial Results - GlobeNewswire
globenewswire.com - August 6 at 7:38 AM
seekingalpha.com logoCytokinetics, Incorporated (CYTK) CEO Robert Blum on Q2 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 6 at 1:14 AM
benzinga.com logoCytokinetics: Q2 Earnings Insights - Benzinga
benzinga.com - August 5 at 8:14 PM
finance.yahoo.com logoCytokinetics Reports Second Quarter 2021 Financial Results - Yahoo Finance
finance.yahoo.com - August 5 at 8:14 PM
finance.yahoo.com logoCytokinetics Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 5 at 8:14 PM
finance.yahoo.com logoCytokinetics (CYTK) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 5 at 8:14 PM
nasdaq.com logoAnnouncing: Cytokinetics (NASDAQ:CYTK) Stock Soared An Exciting 333% In The Last Three Years
nasdaq.com - August 4 at 8:20 AM
markets.businessinsider.com logoHere's what to expect from Cytokinetics's earnings report - Markets Insider
markets.businessinsider.com - August 3 at 9:43 AM
globenewswire.com logoCytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis - GlobeNewswire
globenewswire.com - August 2 at 7:51 AM
finance.yahoo.com logoCytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis
finance.yahoo.com - August 2 at 7:51 AM
Get Cytokinetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/17/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.